BÜHLMANN fCAL® turbo and CALEX® Cap— 510(k) K232057
Substantially EquivalentBühlmann Laboratories AG
FDA 510(k) clearance K232057 for BÜHLMANN fCAL® turbo and CALEX® Cap, Substantially Equivalent on 2024-02-06. Applicant: Bühlmann Laboratories AG.
Clearance details
- Applicant
- Bühlmann Laboratories AG
- Product code
- Code NXO
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Schönenbuch, CH
Data sourced from openFDA. This site is unofficial and independent of the FDA.